FDA Approved: ORGOVYX — Supplemental Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ORGOVYX (relugolix) submitted by Sumitomo Pharma America, expanding the labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ORGOVYX (RELUGOLIX)

Snippet

SUPPL AP for ORGOVYX (RELUGOLIX)